Virtual Medicinal Product (VMP)
-
Nalbuphine 20mg/2ml solution for injection ampoules
Name Details
|
Current Name
Nalbuphine 20mg/2ml solution for injection ampoules
|
Start Date
21-01-2009
|
End Date
|
|
Previous Name
Nalbuphine 20mg/2ml solution for infusion ampoules
|
Start Date
19-01-2009
|
End Date
20-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular, Intravenous, Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular, solutioninjection.intravenous, solutioninjection.subcutaneous, solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N02AF02
| BNF |
|
Current BNF
04070200
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
04070200
|
Start Date
21-02-2005
|
End Date
07-04-2005
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 36028811000001103 |
29-10-2018 |
|
| 322597004 |
11-03-2003 |
28-10-2018 |
VMP Ingredients
Name
Nalbuphine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Nalbuphine
-
VMP
(Current) Nalbuphine 20mg/2ml solution for inj...
Virtual Medicinal Product Pack (VMPP) Information